KBNT - Kubient Technologies slumps 7.5% as Maxim cuts PT to $6

Maxim Group analyst Jack Vander Aarde cut the target on Kubient (KBNT -0.6%) to $6 from $9. However, it maintains a buy rating. Analyst adds: ' The company's Q4 results reflect its early-stage growth investments and headcount expansion, the analyst tells investors in a research note. Vander Aarde adds that as Kubient on-boards more engineers to support faster testing and integrations, while also building out its sales team to attract more demand-side customers to match the number of supply-side customers, the company's revenue growth should accelerate.' The stock has a market cap of $22.9M and has lost about 77% over the last one year.

For further details see:

Kubient Technologies slumps 7.5% as Maxim cuts PT to $6